Adagio Medical Holdings, Inc. is a medical device company, which engages in the development and placing on the EU market of innovative ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in New York, NY.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company